藥物成份

共有 21386 個藥物成份

R1 : Substrate Slide ; \nC1 : Positive Control ; \nC0 : Negative Control. ;\nR2 : Universal FITC Conjugate. ;\nR3 : Mounting Media ; \nR4 : Phosphate Buffer Saline, pH 7.3 ± 0.1\nR5 : Evan Blue Counterstain ; \nBlotting Strip.

• 關聯藥證數量: 1

R1 : TRIS pH7.65 80 mmol/l\n L-Aspartate 240 mmol/l\n MDH(malate dehydrogenase) ≧600 U/l\n LDH(lactate dehydrogenase) ≧900 U/l\nR2 : 2-Oxoglutarate 12 mmol/l\n NADH 0.18 mmol/l

• 關聯藥證數量: 1

R1 : Urea 8.33 mmol/l (0.5 g/l)\nR2 : Urease ≧350 kU/I\nR3 : Phosphate buffer pH 8 50 mmol/l ; Sodium salicylate 62 mmol/l ; Sodium nitroprusside 3.35mmol/l ; EDTA 1 mmol/l\nR4 : Sodium hydroxide (NaOH)* 0.5 mmol/l ; Sodium hypochlorite (NaClO) 24.8 mmol/l

• 關聯藥證數量: 1

R1 Acetate buffer：35 mmol/L, pH 5.3; PEG; detergent; preservative R2 Polyclonal anti-human α1-microglobulin antibody (sheep), dependent on titer; acetate buffer：50 mmol/L, pH 5.3;preservative

• 關聯藥證數量: 1

R1 Anti-amikacin antibody (mouse monoclonal)；human-sourced material in buffer with preservative\nR2 Conjugated amikacin derivative microparticles；human-sourced material in buffer with preservative

• 關聯藥證數量: 1

R1 Anti-gentamicin monoclonal antibody (mouse) in buffer, pH 7.5.

• 關聯藥證數量: 1

R1 Anti-procainamide antibody (mouse monoclonal), G6P, NAD, preservatives and stabilizers

• 關聯藥證數量: 1

R1 Antibody Reagent\n BIS-TRIS buffer: 0.25 mol/L, pH 6.4; anti-digoxin antibodies (mouse monoclonal): ≦ 1.0 mg/L\nR2 Microsphere Reagent\n latex particles coated with digoxin

• 關聯藥證數量: 1

R1 Antibody Working Soluiton：\nSecobarbital antibody (sheep polyclonal) in buffer with bovine serum albumin and 0.09% sodium azide\nR2 Microparticle Working Solution：\nConjugated secobarbital derivative microparticles in buffer and 0.09% sodium azide

• 關聯藥證數量: 1

R1 Antibody Working Solution\n PCP antibody (mouse monoclonal) in buffer \n with bovine serum albumin and 0.09% sodium azide\nR2 Microparticle Working Solution\n Conjugated PCP derivative microparticles in buffer \n and 0.09% sodium azide

• 關聯藥證數量: 1

R1 Antibody Working Solution\n Propoxyphene antibody (goat polyclonal) in \n buffer with bovine serum albumin and 0.09% \n sodium azide\nR2 Microparticle Working Solution\n Conjugated propoxyphene derivative microparticles\n in buffer and 0.09% sodium azide\n

• 關聯藥證數量: 1

R1 Antibody Working Solution\n Propoxyphene polyclonal (goat) antibody in buffer with bovine serum albumin\nR2 Microparticle Working Solution\n Conjugated propoxyphene derivative microparticles in buffer

• 關聯藥證數量: 1

R1 Antibody reagent \nMES buffer: 0.025 mol/L; TRIS buffer: 0.015 mol/L; pH 6.2; HbA1c antibody (bovine serum): ≧0.5 mg/mL; stabilizers; preservatives (liquid)\nR2 Polyhapten reagent \nMES buffer: 0.025 mol/L; TRIS buffer: 0.015 mol/L; pH 6.2; HbA1c polyhapten: ≧8 μg/mL; stabilizers; preservatives (liquid)

• 關聯藥證數量: 1

R1 Antibody reagent \nMES buffer: 0.025 mol/L; TRIS buffer: 0.015 mol/L; pH 6.2; HbA1c antibody (ovine serum): ≧0.5 mg/mL; stabilizers; preservatives (liquid)\nR2=SR Polyhapten reagent \nMES buffer: 0.025 mol/L; TRIS buffer: 0.015 mol/L; pH 6.2; HbA1c polyhapten: ≧8 μg/mL; stabilizers; preservatives (liquid)

• 關聯藥證數量: 1

R1 Antibody reagent in vial A and B (liquid) Anti-procainamide monoclonal antibody (mouse)R2=SR Tracer reagent in vial C (liquid). Fluorescein-labeled procainamide.

• 關聯藥證數量: 1

R1 Antibody reagent in vial B (liquid).\nR2=SR Enzyme reagent in vial c (liquid).

• 關聯藥證數量: 1

R1 Antibody/substrate reagent\n Anti-N-acetylprocainamide antibody (mouse \n monoclonal), G6P and NAD in buffer\nR2 Enzyme reagent N-acetylprocainamide labeled \n with bacterial G6PDH in buffer

• 關聯藥證數量: 1

R1 Antibody/substrate reagent\n Anti-valproic acid antibody (mouse monoclonal)\n , G6P, NAD and bovine serum albumin in buffer\nR2 Enzyme reagent\n Valproic acid labeled with bacterial G6PDH, \n and bovine serum albumin in buffer

• 關聯藥證數量: 1

R1 Arsenazo-Ⅲ Dye 0.94 mmol/L Sodium Acetate 271 mmol/L

• 關聯藥證數量: 1

R1 BICIN3 buffer: 50 mmol/L, colipase ≧ 1 mg/L; Na-deoxycholate: 1.6 mmol/L; calcium chloride: 10 mmol/L\nR2 Tartrate buffer: 10 mmol/L, pH 4.0; 1,2-O-dilauryl-rac-glycero-3-glutaric acid-(6-methylresorufin) ester: 0.27 mmol/L; taurodeoxycholate: 8.8 mmol/L

• 關聯藥證數量: 1

R1 BICINa buffer: 50 mmol/L, pH 8.0; colipase ≧1 mg/L; Na-deoxycholate: 1.6 mmol/L; calcium chloride: 10 mmol/L; detergent; presrvative\nR2 Tartrate buffer: 10 mmol/L, pH4.0; 1,2-O-dilauryl-rac-glycero-3-glutaric acid-(6-methylresorufin) ester: 0.27 mmol/L; taurodeoxycholate: 8.8 mmol/L; detergent; presrvative\na) BICIN = N,N-bis(2-hydroxyethyl)-glycine

• 關聯藥證數量: 1

R1 Benzodiazepines antibody (sheep polyclonal); buffer; β-glucuronidase enzyme; bovine serum albumin (BSA); 0.09 % sodium azide\nR2 Conjugated benzodiazepine derivative microparticles; buffer; 0.09 %\n sodium azide\n

• 關聯藥證數量: 1

R1 Buffer in vial A (liquid). R2= SR Creatine phosphate in vial C (liquid), detail see labeling.

• 關聯藥證數量: 1

R1 Buffer in vial B (liquid) CAPS (3-[Cyclohexylamino]-1-propanesulfonic acid) 525 mmol/L NaOH 400 mmol/L pH 11.3nonreactive surfactantR2=SR o-Cresolphthalein complexone in vial C (liquid) o-Cresolphthalein complexone 0.5 mmol/L 8-Hydroxyquinoline 30 mmol/L pH 1.3 nonreactive stabilizer.

• 關聯藥證數量: 1

R1 Buffer, pH 8.0; rabbit serum, stabilizers and preservative.\nR2 Buffer containing latex particles coated with rabbit anti-human ferritin antibodies, stabilizers and preservative.

• 關聯藥證數量: 1

R1 Buffer,enzymes in vial A(liquid)\nR2=SR Buffer,enzymes,4-aminoantipyrine in vial C(liquid)\nActive ingredients\nR1\nHydrogen donor 1.75 mmol/L\nAscorbate oxidase 510μkat/L\n(cucumber)\nSR\n4-aminoantipyrine 5 mmol/L\nLactate oxidase(microbial) 251μkat/L\nPeroxidase(horseradish) 401μkat/L\nThe reagent contains nonreactive stabilizer and preservatives.\n

• 關聯藥證數量: 1

R1 Buffer; 0.09% sodium azide\nR2 Benzodiazepines antibody (sheep polyclonal);\n buffer; bovine serum albumin; 0.09% sodium zaide\nR3 Conjugated benzodiazepine derivative \n microparticles; buffer; 0.09% sodium azide

• 關聯藥證數量: 1

R1 Buffer; 0.09% sodium azide\nR2 PCP antibody (mouse monoclonal); buffer; bovine serum albumin; 0.09% sodium azide\nR3 Conjugated PCP derivative microparticles; buffer; 0.09% sodium azide

• 關聯藥證數量: 1

R1 Buffer; preservatives; surfactants\nR2 BCP: 526 μmol/L; buffer; preservatives; surfactant

• 關聯藥證數量: 1

R1 Buffer; preservatives\nSR NAD (yeast): ≧3 mmol/L; ADH (EC 1.1.1.1; yeast; 25℃):≧617 μkat/L (37 U/mL); stabilizers; preservatives

• 關聯藥證數量: 1

R1 Buffer\n Tris Buffer 500 mmol/, pH 11.25\n EGTA 90 μmol/l\nR2 Xylidyl Blue\n Xylidyl blue 0.28 mmol/l\n Detergent

• 關聯藥證數量: 1

R1 CAPS (3-[cyclohexylamino]-1-propanesulfonic acid): 525 mmol/L; NaOH: 400 mmol/L: pH11.3; nonreactive surfactant.\nSR o-cresolphthalein complexone: 0.5 mmol/L; 8-hydroxyquinoline: 30 mmol/L; pH 1.3; stabilizer.

• 關聯藥證數量: 1

R1 CCP~biotin (gray cap), 1 bottle, 9 mL:Biotinylated cyclic citrullinated peptides (synthetic) approx. 1.1 μg/mL, phosphate buffer 100 mmol/L, pH 5.0; preservative.

• 關聯藥證數量: 1

R1 Carbamazepine biotinylated hapten; 2-(N-Morpholino) ethanesulfonic acid (MES) buffer; pH 6.4; preservative; surfactant\nR2 Anti-carbamazepine antibody (mouse monoclonal); streptavidin coated latex microparticles: 0.08%; N-(2-Hydroxyethyl)piperazine-N-(2-ethanesulfonic acid) (HEPES) buffer; pH 7.5; preservative

• 關聯藥證數量: 1

R1 Citrate in vail A (liquid).\nR2 Tartrate in vial B (liquid).\nR3=SR 1-Naphthylphosphate in vial C (granulate).\nActive ingredients\nfollowing concentrations (R1,R2,SR, NPACP Test, and ACP Test, respectively)：\nCitric acid：115, 115, N/A, 28, 28 mmol/L\n1,5-Pentanediol：830, 830, N/A, 200, 200 mmol/L\nTartrate：N/A, 415, N/A, 100, N/A mmol/L\n1-Naphthylphosphate：N/A, N/A, 15, 3, 3 mmol/L\nFast Red TR salt：N/A, N/A, 5, 1, 1 mmol/L

• 關聯藥證數量: 1

R1 Coenzyme \n Capso Buffer : 5 mmol/l, pH 9.65 ; NADH : ≧0.23 μmol/l\nR2 Enzymes/Substrate\n Bicine Buffer : 1 mol/l ; Urease : ≧16.2 U/ml ; GLDH : ≧0.9 U/ml ; <-oxoglutarate : ≧18.6 mmol/l

• 關聯藥證數量: 1

R1 Conjugate Reagent \n Phenobarbital conjugate; Piperazine-N, \n N’-bis (ethanesulfonic acid) (PIPES) buffer pH\n　 7.85; preservative; stabilizer\nR2 Latex-Antibody Reagent\n Anti-phenobarbital antibody (mouse monoclonal); \n latex microparticle; 3-(N-morpholino) propane\n sulfonic acid (MOPS) buffer pH 7.4; stabilizer; \n preservative

• 關聯藥證數量: 1

R1 Conjugate Reagent\n Theophylline conjugate;Piperazine-N,N-bis(ethanesulfonuc acid)( PIPES) buffer pH7.2.\nR2 Latex-Antibody Reagent\n Anti-theophylline antibody(mouse monoclonal); latex microparticle;3-(N-morpholino)propane sulfonic acid (MOPS) buffer pH 7.5.

• 關聯藥證數量: 1

R1 Conjugated benzoylecgonine; derivative; buffer; bovine serum; albumin; 0.09% sodium azide\nR2 Microparticles attached to benzoylecgonine antibody (mouse monoclonal); buffer; bovine serum albumin; 0.09% sodium azide

• 關聯藥證數量: 1

R1 Conjugated cannabinoid derivative; buffer; bovine serum albumin; 0.09% sodium azide\nR2 Microparticles attached to cannabinoid antibody (mouse monoclonal); buffer; bovine serum albumin; 0.09% sodium azide

• 關聯藥證數量: 1

R1 Conjugated morphine derivative; buffer; bovine serum albumin; 0.09% sodium azide\nR2 Microparticles attached to morphine antibody (mouse monoclonal); buffer; bovine serum albumin; 0.09% sodium azide

• 關聯藥證數量: 1

R1 Detergent; hydrochloric acid: 120 mmol/L\nR2 3,5-dichlorophenyl diazonium salt: >=1.5 mmol/L

• 關聯藥證數量: 1

R1 EA Solution \nenzyme acceptor (microbial) : 0.25 g/l ;anti-valproic acid antibody (mouse monoclonal) : 24 mg/l ; N-(2-Hydroxyethyl) piperazine-N-(2-ethanesulfonic) (HEPES) acid buffer ; bovine serum albumin ; sodium salicylate ; buffer salts ; stabilizers ; preservative. \nR2 ED Solution \nenzyme donor (microbial)-valproic acid conjugate : 40 μg/l ; chlorophenol red-β-D-galactopyranoside : 2.4 g/l ; goat anti-mouse antibodies : 27 ml/l ; N-(2-Hydroxyethyl) piperazine-N-(2-ethane-sulfonic) (HEPES) acid buffer ; buffer salts ; stabilizers ; preservative.\n\n

• 關聯藥證數量: 1

R1 EA Working Solution\nR2 ED Working Solution

• 關聯藥證數量: 1

R1 EA working solution\nanti-carbamazepine antibody (mouse monoclonal): 49 mg/L; enzyme acceptor (microbial): 0.171 g/L; 3-(N-morpholino) propane sulfonic acid (MOPS) buffer; stabilizer; buffer salts; preservative

• 關聯藥證數量: 1

R1 ED working solution\nenzyme donor (microbial)-phenobarbital: 38 μg/L; chlorophenol red-β-D-galactopyranoside: 1.64 g/L; anti-phenobarbital antibody (mouse monoclonal): 16.1 mg/L; 3-(N-morpholino)propanesulfonic acid (MOPS) buffer; buffer salts; preservative

• 關聯藥證數量: 1

R1 EDTA: 150 mmol/L.\nR2 Sulfanilic acid: 29 mmol/L; hydrochloric acid: 170 mmol/L\nR2a Sodium nitrite: 25 mmol/L

• 關聯藥證數量: 1

R1 Enzyme reagent\n Tobramycin labeled with bacterial G6PDH in buffer\nR2 Antibody/substrate reagent \n Anti-tobramycin antibody (sheep polyclonal), G6P\n , NAD and bovine serum albumin in buffer

• 關聯藥證數量: 1

R1 Enzyme reagent\n Vancomycin labeled with bacterial G6PDH in buffer\nR2 Antibody/substrate reagent\n Anti-vancomycin antibody (mouse monoclonal)\n , G6P and NAD in buffer

• 關聯藥證數量: 1

R1 Enzyme:\nTris buffer 100mmol/l, pH7.5\nL-alanine 0.5mol/l\nLD >1.2U/ml\nR2 α-oxoglutarate/Conezyme\na-oxoglutarate 15 mmol/l\nNADH 0.8mmol/l

• 關聯藥證數量: 1

R1 Gentamicin conjugate; piperazine-N, N’-bis (ethanesulfonic acid) (PIPES) buffer, pH 7.2; preservative\nR2 Anti-gentamicin antibody (mouse monocloanl); latex microparticle; 3-(N-morpholino) propane sulfonic acid (MOPS) buffer, pH 7.5; stabilizer; preservative

• 關聯藥證數量: 1

R1 Glycine buffer 170 mmol/l, pH 8.3; polyethylene glycol 0.05% bovine serm albumin; preservatives and stabilizers.\nR2 Latex particles coated with human IgG

• 關聯藥證數量: 1

R1 HEPES: 52.4 mmol/L; Sodium chloride: 87 mmol/L; Calcium chloride: 0.08 mmol/L; Magnesium chloride: 12.6 mmol/L; α-Glucosidase (microbial): &#8805;66.8 μkat/L; pH 7.0 (37°C); preservatives; stabilizers\nSR HEPES: 52.4 mmol/L; Ethylidene-G7-PNP: 22 mmol/L; pH 7.0 (37°C); preservatives; stabilizers

• 關聯藥證數量: 1

R1 Imidazole buffer: 123 mmol/L, pH 6.5 (37 °C); EDTA:\n 2.46 mmol/L; Mg2+: 12.3 mmol/L; ADP: 2.46 mmol/L; AMP:\n 6.14 mmol/L; diadenosine pentaphosphate: 19 μmol/L; NADP\n (yeast): 2.46 mmol/L; N-acetylcysteine: 24.6 mmol/L; HK\n (yeast): &#8805; 36.7 μkat/L (25 °C); G6P-DH (E. coli): &#8805; 23.4 μkat/L\n (25 °C); preservative; stabilizer; additive.\nR3 CAPSO* buffer: 20 mmol/L, pH 8.8 (37 °C); glucose:\n 120 mmol/L; EDTA: 2.46 mmol/L; creatine phosphate:\n 184 mmol/L; 4 monoclonal anti-CK-M antibodies (mouse),\n inhibiting capacity: > 99.6 % up to 66.8 μkat/L (4000 U/L) (37 °C)\n CK-M subunit; preservative; stabilizer; additive.\n

• 關聯藥證數量: 1

R1 Imidazole: 58.0 mmol/L, pH 6.00; N-acetylcysteine: 40.0 mmol/L; EDTA: 3.00 mmol/L; AMP: 10.0 mmol/L; diadenosine pentaphosphate: 24.0μmol/L; NADP+: 9.5 mmol/L; Mg2+: 20.0 mmol/L; D-glucose: 40.0 mmol/L; preservative; stabilizer.

• 關聯藥證數量: 1

R1 Imidazole: 58.0 mmol/L, pH 6.0; N-acetylcysteine: 40.0 mmol/L; EDTA:\n 3.0 mmol/L; AMP: 10.0 mmol/L; diadenosine pentaphosphate: 24.0 μmol/L;\n NADP+: 9.5 mmol/L; Mg2+: 20.0 mmol/L; D-glucose: 40.0 mmol/L; stabilizer\nR2 EDTA: 3.0 mmol/L, pH 9.1; HK (yeast): &#8805; 600 μkat/L; G6PDH\n (microbial): &#8805; 600 μkat/L; ADP: 12.0 mmol/L; creatine phosphate:\n 180 mmol/L; N-methyldiethanolamine: 69.0 mmol/L; monoclonal murine\n antibodies inhibiting human CK-M (inhibiting capacity &#8805; 2000 U/L of\n CK-MM); preservative; stabilizer; detergent

• 關聯藥證數量: 1

R1 Imidazole: 58.0 mmol/L, pH: 6.00; N-acetylcysteine: 40.0 mmol/L; EDTA: 3.00 mmol/L; AMP: 10.0 mmol/L; diadenosine pentaphosphate: 24.0 μmol/L; NADP+: 9.5 mmol/L; Mg2+: 20.0 mmol/L; D-glucose: 40.0 mmol/L; stabilizer.

• 關聯藥證數量: 1

R1 Intrinsic factor~Ru(bpy)2+ 3 (gray cap), 1 bottle, 10 mL:Ruthenium labeled porcine intrinsic factor 4 μg/L; cobinamide dicyanide 15 μg/L; stabilizer; human serum albumin; phosphate buffer, pH 5.5; preservative.

• 關聯藥證數量: 1

R1 MES buffer: 5.0 mmol/L, pH 6.0; Mg2+: 24 mmol/L; ATP: ≧4.5 mmol/L; NADP:≧7.0 mmol/L; preservative\nR2 HEPES buffer: 200 mmol/L; pH 8.0; Mg2+: 4 mmol/L; HK (yeast):≧300 μkat/L; G-6-PDH (E.coli):≧300 μkat/L; preservative

• 關聯藥證數量: 1

R1 MOPS(3-morpholinopropane sulfonic acid buffer):20.1 mmol/L,pH6.5;HSDA:0.96 mmol/L;ascorbate oxidase(Eupenicillium spec.,recombinant);≧50μkat/L;peroxidase(horseradish): ≧167μkat/L;preservativeR2 MOPS(3-morpholinopropane sulfonic acid buffer):20.1 mmol/L, pH6.8;MGSO4．7H2O:8.11 mmol/L;4-aminoantipyrine:2.46mmol/L;cholesterol esterase(Pseudomonas spec.): ≧50μkat/L;cholesteroloxidASE(Brevibacterium spec., recombinant): ≧33.3μkat/L;peroxidase(horseradish) ≧333μkat/L;detergent;preservative

• 關聯藥證數量: 1

R1 Microplate: 12 strips of 8 wells coated with monoclonal antibodies to p24 HIV1 (mouse) and purified HIV1 and HIV2 antigens\nR2 Concentrated washing solution (20X): Tris NaCl buffer pH 7.4, ProClin 300 0.04%\nR3 Negative control: Heat inactivated human plasma negative for HBs antigen, HIV antigen, anti-HIV1, anti-HIV2 and anti-HCV antibodies, Sodium azide < 0.1%\nR4 HIV Ab positive control: Heat inactivated human plasma positive for anti-HIV antibodies, negative for HIV and HBs antigens and anti-HCV antibodies, in synthetic diluent, ProClin 300 < 0.1%\nR5 HIV Ag positive control: Purified HIV1 antigen inactivated with a chaotropic agent, in synthetic diluent, ProClin 300 < 0.1%\nR6 Conjugate 1: biotinylated polyclonal antibodies to p24 HIV1 (sheep), ProClin 300 0.5%\nR7a Conjugate 2: Lyophilised peroxidase labelled Streptavidin and purified HIV1 and HIV2 antigens\nR7b Conjugate 2 Diluent: kimmed milk solution, ProClin 300 0.5%

• 關聯藥證數量: 1

R1 N-methylglucamine：400 mmol/l, pH 9.4 (37℃);lithium lactate：61 mmol/l R2： NAD：60 mmol/l; stabilizers and preservatives

• 關聯藥證數量: 1

R1 NADH\n NADH 0.18 mmol/l\nR2 Pyruvate 0.6 mmol/l\n Phosphate buffer 17mmol/l, pH7.5\n

• 關聯藥證數量: 1

R1 NBT Reagent/buffer (bottles 1 and 1a) \nNitrotetrazolium-blue: 0.57 mmol/L; sodium cholate: 4.9mmol/L; potassium chloride: 49 mmol/L; potassium phosphate buffer: 49 mmol/L, potassium carbonate buffer: 250 mmol/L, pH 10.3; uricase: &#8805;2.8 kU/L (Arthrobacter species); detergent: 2.1%

• 關聯藥證數量: 1

R1 NaCl 9 %\nR3 TRIS buffer: 220 mmol/L, pH 8.6; 2-oxoglutarate: 73 mmol/L;\nNADH: 2.5 mmol/L; ADP: 6.5 mmol/L; urease (jack bean): &#8805; 300 μkat/L;\nGLDH (bovine liver): &#8805; 80 μkat/L; preservative; nonreactive stabilizers

• 關聯藥證數量: 1

R1 Nitroblue tetrazolium: 1.2 mmol/L; uricase (microbial):&#8805;12 μkat/L; pH7.5 non-reactive buffer; stabilizer; surfactants\nR3 Carbonate buffer: 1.5 mol/L; pH10.4\n

• 關聯藥證數量: 1

R1 Non-reactive surfactants and stabilizer at an acidic pH.\nR2 4mM Ferenes, 480mM ascorbic acid and non-reactive stabilizers.

• 關聯藥證數量: 1

R1 Oxalate Crystal violet solution;\nR2 Stabilized Lugol-PVP;\nR3 Decolorizer;\nR4 Safranin solution

• 關聯藥證數量: 1

R1 Phenytoin conjugate; Piperazine-N, N’-bis (ethanesulfonic acid) (PIPES) buffer pH 7.3.\nR2 Anti-phenytoin antibody (mouse monoclonal) ; latex microparticle 3-(N-morpholino) propane sulfonic acid (MOPS) buffer pH 7.4.

• 關聯藥證數量: 1

R1 Phenytoin conjugated; piperazine-N,N’-bis (ethanesulfonic acid) (PIPES) buffer, pH 7.3; stabilizer; preservative\nR2 Anti-phenytoin antibody (mouse monoclonal); latex microparticle; 3-(N-morpholino) propane sulfonic acid (MOPS) buffer, pH 7.4; stabilizer; preservative

• 關聯藥證數量: 1

R1 Phosphate buffer: 12.7 mmol/L, pH 7.2; NaCl: 130 mmol/L; PEG: 40g/L; preservative in vial A (liquid).\nR2=SR Anti-human haptoglobin antibody (rabbit)>1.1g/L; NaCl: 100 mmol/L; preservative in vial C (liquid).

• 關聯藥證數量: 1

R1 Phosphate buffer: 12.7 mmol/L, pH 7.2; sodium chloride:0.13 mol/L; PEG: 40 g/L; preservativeR2 Anti-human haptoglobin antibodies (rabbit): >1.1 g/L;NaCl: 0.10 mol/L; preservative

• 關聯藥證數量: 1

R1 Phosphate buffer: 60mmol/L, pH 7.5; NaCl 100 mmol/L;\nEDTA: 1.0mmol/L; PEG: 3%; preservative\nR2 Anti-human lipoprotein (a) antibodies (rabbit): dependent on\ntiter; NaCl: 100 mmol/L; stabilizer; preservative

• 關聯藥證數量: 1

R1 Phosphate buffer：12.7 mmol/l, pH 7.2;NaCl：0.13 mol/l; PEG：60g/l; preservative R2 Anti-human prealbumin antibody(rabbit)：>0.55 g/l;NaCl：0.10 mol/l;preservative

• 關聯藥證數量: 1

R1 Phosphate buffer：60.7 mmol/L, pH 7.7; 5,5'-dithiobisnitrobenzoic acid：0.3 mmol/L; preservative R2 Butyrylthiocholine iodide：42.5 mmol/L; preservative

• 關聯藥證數量: 1

R1 Phosphoenolpyruvate: >60 mmol/L; NADH analog: 3 mmol/L; MDH (porcine):≧1200 nkat/L; PEPC (microbial):≧120 nkat/L

• 關聯藥證數量: 1

R1 Phosphoenolpyruvate：≧40 mmol/L；NADH analog：≧2.0 mmol/L；MDH (porcine)：≧314.3 μkat；PEPC (microbial)：≧30.8 μkat

• 關聯藥證數量: 1

R1 Potassium hydroxide: 900 mmol/L; Phosphate: 135 mmol/L; pH: ≧13.5; preservative; stabilizer.\nSR Picric acid: 38.2 mmol/L; pH: 6.5; preservative; stabilizer.

• 關聯藥證數量: 1

R1 Sodium hydroxide: 530 mmol/L; EDTA-Na: 74 mmol/LR2 Benzethonium chloride: 32 mmol/L

• 關聯藥證數量: 1

R1 Stabilizing Solution\nR-2 Latex Solution\n Latex coated with anti-AFP polyclonal antibody

• 關聯藥證數量: 1

R1 Sulfamic (H3NO3S): 110 mmol/L; sodium acetate buffer (C2H3NaO2): 85 mmol/L; surfactant; solubilizer\nR2=SR Diazonium ion: 3 mmol/L; HCl: 100 mmol/L

• 關聯藥證數量: 1

R1 Sulfanilic acid in vial A (liquid): Sulfanilic acid 35 mmol/L, Oxalic acid 40 mmol/L, HEDTA 4 mmol/L, Myristyltrimethyl-ammonium bromide 2 %, Dodecyltrimethyl-ammonium bromide 5 %, pH 1.1.\nR2 Nitrite in vial B (liquid): Sodium nitrite 24.5 mmol/L, pH 6.8.

• 關聯藥證數量: 1

R1 Sulfanilic acid: 35 mmol/L; HEDTA: 4.0 mmol/L; oxalic acid: 40 mmol/L; pH 1.2\nR2 Sodium nitrite: 3.9 mmol/L; pH 6.0

• 關聯藥證數量: 1

R1 TES/HCl buffer: 20 mmol/L, pH 7.7; NaCl: 500 mmol/L; preservative\nR2 Latex particles coated with monoclonal anti-human sTfR antibody (mouse); TRIS/HCl buffer: 20 mmol/L, pH 8.0; preservative

• 關聯藥證數量: 1

R1 TRIS (hydroxymethyl)-aminomethane buffer: 16 mmol/L\nR2 Latex particles coated with anti-CRP mouse monoclonal antibodies: 0.1%; glycine buffer: 50 mmol/L

• 關聯藥證數量: 1

R1 TRIS buffer 20 mmol/L, pH8.0; NaCl:200 mmol/L; polyethylene glycol:3.6%; preservative; stabilizers\nR2 Anti-human IgA antibody (goat): dependent on titer; TRIS buffer: 20 mmol/L, pH 8.0 NaCl: 150 mmol/L; preservative

• 關聯藥證數量: 1

R1 TRIS buffer with bovine serum albumin and immunoglobulins (mouse); preservative; stabilizers\nR2 Latex particles coated with anti-CRP (mouse) in glycine buffer; preservative; stabilizers

• 關聯藥證數量: 1

R1 TRIS buffer with bovine serum albumin; preservatives.\nR2 Latex particles coated with anti-CRP (mouse) in glycine buffer; immunoglobulins (mouse); preservative.

• 關聯藥證數量: 1

R1 TRIS buffer, PEG, EDTA, and preservative.\nR2 Polyclonal anti-human albumin antibodies, TRIS buffer, preservative.

• 關聯藥證數量: 1

R1 TRIS buffer, pH 7.5; immunoglobulins (rabbit); preservative, stabilizers\nR3 Aqueous matrix containing latex particles coated with anti-human ferritin antibodies (rabbit); preservative, stabilizers

• 關聯藥證數量: 1

R1 TRIS buffer: 100 mmol/L, pH 7.8; Mg2+: 4 mmol/L; ATP: ≧1.7 mmol/L; NADP : ≧1.0 mmol/L; preservative\nSR HEPES buffer: 30 mmol/L, pH 7.0; Mg2+: 4 mmol/L; HK (yeast): ≧130 μkat/L; G-6-PDH (E.coli):≧250 μkat/L; preservative

• 關聯藥證數量: 1

R1 TRIS buffer: 20 mmol/L, pH 8.0; NaCl: 200 mmol/L; polyethylene glycol: 3.6%; preservative; stabilizers\nR2 Anti-human IgM antibody (goat): dependent on titer; TRIS buffer: 20 mmol/L, pH 8.0; NaCl: 150 mmol/L; preservative

• 關聯藥證數量: 1

R1 TRIS buffer: 220 mmol/L, pH 8.6; 2-oxoglutarate: 73 mmol/L; NADH: 2.5 mmol/L; ADP: 6.5 mmol/L; urease (jack bean):≧300 μkat/L; GLDH (bovine liver):≧80 μkat/L; preservative

• 關聯藥證數量: 1

R1 TRIS buffer: 280 mmol/L, pH 7.3; L-alanine: 1400 mmol/L; NADH: 0.53 mmol/L (yeast); LDH ≧ 3.5 U/mL (microorganisms); preservative

• 關聯藥證數量: 1

R1 TRIS buffer: 50 mmol/L, pH 7.4; preservatives; stabilizers.\nR2 Latex particles coated with anti-CRP mouse monoclonal antibodies: 0.1%; glycine buffer: 50 \nmmol/l, pH 8.0; preservative; stabilizer.\n

• 關聯藥證數量: 1

R1 TRIS buffera: 170 mmol/l, pH 8.2R2 Borate buffer: 10 mmol/l, pH 8.2; latex particles coated with streptolysin O: 2 ml/l

• 關聯藥證數量: 1

R1 TRIS* buffer.\nR2 Latex particles coated with polyclonal anti-human ferritin anti-bodies (rabbit).

• 關聯藥證數量: 1

R1 TRIS* buffer：170 mmol/l,pH8.2\nR2 Borate buffer：100 mmol/l,pH8.2; latex particles coated with streptolysin O：2 ml/l

• 關聯藥證數量: 1

R1 TRISa buffer with bovine serum albumin; preservatives\nR2 Latex particles coated with anti-CRP (mouse) in glycine buffer; immunoglobulins (mouse); preservative

• 關聯藥證數量: 1

R1 Theophylline conjugate; piperazine-N, N’-bis (ethanesulfonic acid) (PIPES) buffer pH 7.2; preservative\nR2 Anti-theophylline antibody (mouse monoclonal); latex microparticle; 3-(N-morpholino) propane sulfonic acid (MOPS) buffer pH 7.5; stabilizer; preservative

• 關聯藥證數量: 1